Les #brevets sur le vivant, ça sert aussi à interdire les recherches indépendantes sur les effets des #OGM :
Multibillion-dollar agricultural corporations, including #Monsanto and Syngenta, have restricted independent research on their genetically engineered crops. They have often refused to provide independent scientists with seeds, or they’ve set restrictive conditions that severely limit research options. This is legal. Under U.S. law, genetically engineered crops are patentable inventions. Companies have broad power over the use of any patented product, including who can study it and how. (...) Whatever the reasons, the results are clear: Public sector research has been blocked. (...) Beyond patent law, agricultural companies hold a pocketbook advantage in terms of research. For example, they fund much of the agricultural safety research done in this country. And when deciding whether to allow a genetically engineered crop onto the market, the Department of Agriculture and other regulatory agencies do not perform their own experiments on the performance and safety of the product; instead, they rely largely on studies submitted by the companies themselves.
►http://www.latimes.com/news/opinion/commentary/la-oe-guriansherman-seeds-20110213,0,2052370.story
Tous cela rejoint les pratiques de l’industrie pharmaceutique.